Pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones: Synthesis, Cyclometalation, and Protein Kinase Inhibition

Abstract

Synthetic routes to pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones are disclosed and examples for their subsequent transformations into cyclometalated protein kinase inhibitors are presented.

Key words

pyridocarbazoles - photocyclization - cyclometalation - ruthenium - protein kinase inhibitors

References

• For metal-based drugs, see:
• 1a Chem. Rev.   Vol. 99:  Orvig C. Abrams MJ. American Chemical Society; Washington DC: 1999.  p.2201 
• 1b Guo Z. Sadler PJ. Angew. Chem. Int. Ed.  1999,  38:  1512 
• 1c Coord. Chem. Rev.   Vol. 232:  Farrell N. Elsevier; Amsterdam: 2002.  p.1 
• For bioorganometallic chemistry, see:
• 2a Severin K. Bergs R. Beck W. Angew. Chem. Int. Ed.  1998,  37:  1634 
• 2b Grotjahn DB. Coord. Chem. Rev.  1999,  190:  1125 
• 2c J. Organomet. Chem.   Vol. 589:  Jaouen G. Elsevier; Amsterdam: 1999.  p.1 
• 2d Metzler-Nolte N. Angew. Chem. Int. Ed.  2001,  40:  1040 
• 2e Fish RH. Jaouen G. Organometallics  2003,  22:  2166 
• 3 Metal complexes as enzyme inhibitors: Louie AY. Meade TJ. Chem. Rev.  1999,  99:  2711 
• 4 Zhang L. Carroll PJ. Meggers E. Org. Lett.  2004,  6:  521 
• 5 Bregman H. Willams DS. Atilla E. Carroll PJ. Meggers E. J. Am. Chem. Soc.  2004,  126:  13594 
• 6a Toledo LM. Lydon NB. Structure  1997,  1551 
• 6b Lawrie AM. Noble MEM. Tunnah P. Brown NR. Johnson LN. Endicott JA. Nat. Struct. Biol.  1997,  796 
• 7 Taylor SS. Radzio-Andzelm E. Curr. Opin. Chem. Biol.  1997,  219 
• 8a Faul MM. Winneroski LL. Krumrich CA. J. Org. Chem.  1998,  63:  6053 
• 8b Faul MM. Winneroski LL. Krumrich CA. Tetrahedron Lett.  1999,  40:  1109 
• 8c Sanchez-Martinez C. Faul MM. Shih C. Sullivan KA. Grutsch JL. Cooper JT. Kolis SP. J. Org. Chem.  2003,  68:  8008 
• 9a Berlinck RGS. Britton R. Piers E. Lim L. Roberge M. Moreira da Roche R. Andersen RJ. J. Org. Chem.  1998,  63:  9850 
• 9b Piers E. Britton R. Andersen RJ. J. Org. Chem.  2000,  65:  530 
• For the analogous synthesis of some pyridyl, quinolinyl, and isoquinolinyl[a]pyrrolo[3,4-c]carbazoles, see:
• 10a Zhu G. Conner S. Zhou X. Shih C. Brooks HB. Considine E. Dempsey JA. Ogg C. Patel B. Schultz RM. Spencer CD. Teichner B. Watkins SA. Bioorg. Med. Chem. Lett.  2003,  13:  1231 
• 10b Sanchez-Martinez C. Shih C. Faul MM. Zhu G. Paal M. Somoza C. Li T. Kumrich CA. Winneroski LL. Xun Z. Brooks HB. Patel BKR. Schultz RM. DeHahn TB. Spencer CD. Watkins SA. Considine E. Dempsey JA. Ogg CA. Campbell RM. Anderson BA. Wagner J. Bioorg. Med. Chem. Lett.  2003,  13:  3835 
• 11 Kita Y. Haruta J. Fujii T. Segwawa J. Synthesis  1981,  451 
• 12 Thummel RP. Hegde V. J. Org. Chem.  1989,  54:  1720 
• 13 Ohkubo M. Nishimura T. Jona H. Honma T. Morishima H. Tetrahedron  1996,  52:  8099 
• A related approach was used to synthesize granulatimides:
• 14a Yoshida T. Nishiyachi M. Nakashima N. Murase M. Kotani E. Chem. Pharm. Bull.  2002,  50:  872 
• 14b Yoshida T. Nishiyachi M. Nakashima N. Murase M. Kotani E. Chem. Pharm. Bull.  2003,  51:  209 
• 15 Qinde L. Mudadu MS. Schmider H. Thummel R. Tao Y. Wang S. Organometallics  2002,  21:  4743 
• 16 Legros J.-Y. Primault G. Fiaud J.-C. Tetrahedron  2001,  57:  2507 
• 17 Gill TP. Mann KR. Organometallics  1982,  1:  485 
• 18 Rüba E. Mereiter K. Soldouzi KM. Gemel C. Schmid R. Kirchner K. Bustelo E. Puerta MC. Valerga P. Organometallics  2000,  19:  5384 
• 19 Williams DS. Atilla GE. Bregman H. Arzoumanian A. Klein PS. Meggers E. Angew. Chem. Int. Ed.  2005,  44:  1984